Home Health Breaking Barriers: Advancing Gene Therapies for Amyotrophic Lateral Sclerosis

Breaking Barriers: Advancing Gene Therapies for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a relentless and complex neurodegenerative disorder that affects the central nervous system, gradually impairing voluntary muscle movement. Referred to as Lou Gehrig’s disease, ALS has fascinated the scientific and medical communities due to its perplexing nature.

ALS is characterized by the degeneration of motor neurons responsible for transmitting signals from the brain to the muscles throughout the body. This progressive loss of motor neurons leads to muscle weakness, paralysis, and eventually respiratory failure. Patients experience a range of symptoms, including muscle cramps, muscle twitching (fasciculations), difficulty swallowing (dysphagia), slurred speech (dysarthria), and muscle stiffness (spasticity). The relentless progression of ALS presents immense challenges for those affected, necessitating a deeper understanding of the disease.

ALS is a global health concern, affecting people of all ethnicities and geographic regions. According to a systematic review and meta-analysis [1], the overall crude worldwide incidence of ALS was 1.59 per 100,000 person-years. The prevalence of ALS increases with age, with the majority of cases diagnosed between the ages of 40 and 70.

Currently, ALS treatment therapies primarily focus on managing symptoms and improving patients’ quality of life. There are three approved medications: riluzole, edaravone, and Relyvrio, two of which have shown moderate efficacy, resulting in a slight increase in survival of several months [2, 3]. Additionally, supportive therapies such as physical and occupational therapy, speech therapy, and assistive technologies help maintain functionality and autonomy. It is important to note, however, that these therapeutic options do not halt or reverse the progression of the disease. This underscores the critical importance of exploring novel techniques to address ALS’s relentless progression in the fight against the disease.

While the majority of ALS cases develop spontaneously, approximately 5-10% of cases exhibit familial patterns, suggesting an underlying genetic predisposition. The identification of SOD1 (superoxide dismutase 1) as the first causal gene for ALS dates back to 1993 [4]. Since then, a number of genes, including C9orf72, TARDBP, FUS, and others, have been linked to the pathophysiology of ALS. These genes play crucial roles in protein regulation, RNA metabolism, and cytoskeleton organization, among other cellular functions. By elucidating the genetic basis of ALS, we not only gain a better understanding of the disease but also open up new avenues for targeted therapeutics and personalized medicine, paving the way for more precise interventions.

In order to gain a better understanding of ALS pathogenesis and develop effective treatments, mouse models play a crucial role. GemPharmatech has developed a proprietary mouse model named B6-hSOD1 G93A, which carries the full-length human SOD1 gene with the G93A mutation, including the human promoter sequence, exons, and introns. This model proves invaluable in evaluating ASO drugs targeting the SOD1 pathway and other ALS therapies. Preliminary validation results demonstrate that this mouse model partially replicates the clinical and behavioral characteristics observed in ALS patients, with disease onset occurring at approximately 5.5 months of age. As a result, it serves as an ideal research tool for investigating ALS pharmacology, drug efficacy, and disease mechanisms.

Figure 1. Muscle histopathology of B6-hSOD1 G93A, hSOD1 male mice

Figure 2. Motor capability changes in B6-hSOD1 G93A, hSOD1 mice

Figure 3. Transcriptome expression profile changes in the spinal cord of B6-hSOD1 G93A, hSOD1 mice at the disease onset

Aside from the well-studied SOD1 gene, GemPharmatech has successfully developed a proprietary mouse model, known as B6-hTDP43 A315T, which specifically targets another crucial gene associated with ALS, TARDBP. This model proves to be an invaluable resource for comprehending the involvement of the TARDBP gene or TDP43 protein in ALS, as well as for evaluating drug effectiveness and elucidating disease mechanisms.

To discover further information about our research and obtain a complimentary quote, we invite you to visit our website today.

 References:

  1. Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, Zhan S, Wang S. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020 Apr;267(4):944-953.
  2. Jaiswal, M.K., Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med Res Rev, 2019. 39(2): p. 733-748.
  3. Chio, A., L. Mazzini, and G. Mora, Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology, 2020. 167: p. 107986.
  4. Deng, H.X., Hentati, A., Tainer, J.A., et al. (1993). Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261, 1047–1051.
Must Read

Body Care for Busy Lifestyles: Time-Saving Products and Hacks

Introduction: In the hustle and bustle of modern life, carving out time for comprehensive body care routines can be challenging. However, prioritizing self-care is crucial...

Body Care for Busy Lifestyles: Time-Saving Products and Hacks

Introduction: In the hustle and bustle of modern life, carving out time for comprehensive body care routines can be challenging. However, prioritizing self-care is crucial...

The Impact of API Quality on Drug Development and Patient Health

In the complex world of pharmaceuticals, active pharmaceutical ingredients (APIs) are crucial elements. Be they natural or synthetic, these essential components form the foundation...

Empowering Wellness: The Role of Pelvic Floor Physiotherapy

Impact Physiotherapy, a renowned center for rehabilitation and wellness in Beaumont, has been providing specialized physiotherapy services. One of their key areas of expertise...

5 Things That Diabetic Patients Should Know About Their Health

Diabetes is not just a single disease, it is a condition that may lead to various other health issues that if left untreated may...

Revealing the Potential of Becosule Capsules Treatment for health 

It is common for maintaining good health to be neglected in our fast-paced society. Our hectic lifestyles, erratic eating habits, and lifestyle choices can...

Knowing Creatinine Levels: An Important Indicator of Kidney Health

Creatinine levels are a key indicator of kidney function and general health. It is essential for preventive health management to comprehend what creatinine is...
Related News

Top 5 Hajj Packages for 2024: A Comprehensive Guide for Pilgrims

Embarking on the sacred journey of Hajj is a profound milestone in a Muslim's life. It's a pilgrimage that requires meticulous planning and preparation....

Chania Airport Car Rental Hacks: Maximizing Your Adventure in Picturesque Crete

Crete, the largest of the Greek islands, is a haven for adventure seekers and culture enthusiasts alike. From the mesmerizing landscapes to the rich...

Kedarnath Yatra: A Spiritual Pilgrimage to the Himalayas

The Kedarnath Yatra is a journey that transcends physical boundaries, taking pilgrims on a spiritual odyssey to one of the holiest shrines in Hinduism....

Discovering Dubai’s Enchantment: A Journey Through Must-Visit Tourist Places

Dubai, a city of luxury and innovation, has evolved into a global tourism hub, blending modern marvels and cultural gems. In this guide, we'll...

Discovering Kuno National Park’s Wonders

A testament to the country's dedication to wildlife conservation, Kuno National Park's wonders is tucked away in the heart of the country. It is...